Top Markets
Coin of the day
Xeno Transplants Corporation Xeno Transplants Corporation

Xeno Transplants Corporation

XENO
Rankning i aktier #42146
Xeno Transplants Corporation functions as a biotechnology firm dedicated to... Xeno Transplants Corporation functions as a biotechnology firm dedicated to research and development. Leveraging a specific licensing agreement with Massachusetts General Hospital, the company aims to innovate, produce, commercialize, and implement products and methodologies for public application in the field of xenotransplantation. The primary objective of this xenotransplantation research is to alleviate the critical scarcity of human cells, tissues, and organs required for medical transplants. This is achieved by pioneering techniques that enable the transfer of biological components—such as cells, tissues, and organs—from non-human species, including pigs, into human recipients. Established in 2004, Xeno Transplants Corporation maintains its headquarters in Brookline, Massachusetts.
Aktiekurs
$0.0001
Senast synkroniserad: 2026-08-11
Marknadsvärde
$4.04K
Förändring (1 dag)
0.00%
Förändring (1 år)
0.00%
Land
CA
Handel Xeno Transplants Corporation (XENO)

Kategori

Historik för aktiesplit för Xeno Transplants Corporation (XENO)
Aktien Xeno Transplants Corporation (symbol: XENO) har genomgått totalt 0 aktiesplitar.
Den senaste spliten skedde den Aug 13, 2026.
En XENO-aktie köpt före Aug 13, 2026 motsvarar nu 0 XENO-aktier.
Lista över aktiesplitar
År Split Multipel Kumulativ multipel
Inte tillräckligt med data för de angivna datumen.
Aktiesplitar för liknande företag eller konkurrenter
Företag Antal aktiesplitar Kumulativ multipel Land
1 x2
US
0 -
NL
0 -
CH
0 -
BE
0 -
KR